MCP-1 inhibitors (Roche/ Iconix)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameMCP-1 inhibitors (Roche/ Iconix)
Drug Alias NameRS-102895RS-21825RS-43276RS-504393
ClassificationSmall molecules
Mechanisms of ActionChemokine receptors antagonistsMonocyte migration inhibitors
TargetsChemokine receptors
Therapy Area/IndicationsAtherosclerosisMultiple SclerosisArthritis, Rheumatoid
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesRoche Palo Alto Llc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsAtherosclerosisMultiple SclerosisArthritis, Rheumatoid

Other Information

ATC CodeN/A
Related LinksN/A